Bronnen autismespectrum stoornissen

1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders [DSM-IV-TR]. Washington, DC: American Psychiatric Association.
2. Willemsen-Swinkels, S.H., Buitelaar, J.K. (2002). The autistic spectrum: subgroups, boundaries, and treatment. Psychiatric Clinics of North America, 25(4): 811-836.
3. Van Engeland, H. (2000). Autisme en psychosen. In: W. Vandereycken, C.A.L. Hoogduin, P.M.G. Emmelkamp (red.). Handboek Psychopathologie: deel 1: basisbegrippen, p. 469-489. Houten: Bohn Stafleu Van Loghum.
4. Lotspeich, L.J., Kwon, H., Schumann, C.M., Fryer, S.L., Goodlin-Jones, B.L., Buonocore, M.H., Lammers, C.R., Amaral, D.G., Reiss, A.L. (2004). Investigation of neuroanatomical differences between autism and Asperger syndrome. Archives of General Psychiatry, 61(3): 291-298.
5. Macintosh, K.E., Dissanayake, C. (2004). Annotation: The similarities and differences between autistic disorder and Asperger's disorder: a review of the empirical evidence. Journal of Child Psychology & Psychiatry, 45(3): 421-434.
6. Mahoney, W.J., Szatmari, P., MacLean, J.E., Bryson, S.E., Bartolucci, G., Walter, S.D., Jones, M.B., Zwaigenbaum, L. (1998). Reliability and accuracy of differentiating pervasive developmental disorder subtypes. Journal of the American Academy of Child and Adolescent Psychiatry, 37(3): 278-285.
7. Howlin, P. (2003). Outcome in high-functioning adults with autism with and without early language delays: Implications for the differentiation between autism and Asperger syndrome. Journal of Autism and Developmental Disorders, 33(1): 3-13.
8. Fombonne, E. (2003). Epidemiological surveys of autism and other pervasive developmental disorders: an update. Journal of Autism and Developmental Disorders, 33(4): 365-382.
9. Van der Gaag, R.J., Van Berckelaer-Onnes, I.A. (2000). Protocol autisme en aan autisme verwante contactstoornissen. In: P. Prins, N. Pameijer (red.). Protocollen in de jeugdzorg: richtlijnen voor diagnostiek, indicatiestelling en interventie, p. 135-155. Lisse: Swets & Zeitlinger.
10. Fitzgerald, M., Corvin, A. (2001). Diagnosis and differential diagnosis of Asperger syndrome. Advances in Psychiatric Treatment, 7(310-318.
11. Rutter, M., Andersen-Wood, L., Beckett, C., Bredenkamp, D., Castle, J., Groothues, C., Kreppner, J., Keaveney, L., Lord, C., O'Connor, T.G. (1999). Quasi-autistic patterns following severe early global privation. Journal of Child Psychology & Psychiatry, 40(4): 537-549.
12. Ormel, J., Neeleman, J., Wiersma, D. (2001). Determinanten van psychische ongezondheid: implicaties voor onderzoek en beleid. Tijdschrift voor Psychiatrie, 43(4): 245-257.
13. Van den Ban, E.F., Buitelaar, J.K. (2002). Genderverschillen bij ADHD en autisme op jonge leeftijd. Tijdschrift voor Psychiatrie, 44(6): 403-408.
14. Van der Gaag, R.J. (2003). Autismespectrumstoornissen: oorzakelijke factoren. Tijdschrift voor Psychiatrie, 45(9): 549-558.
15. Hughes, C., Leboyer, M., Bouvard, M. (1997). Executive function in parents of children with autism. Psychological Medicine, 27(1): 209-220.
16. Happe, F., Frith, U. (1996). The neuropsychology of autism. Brain, 119(Pt 4): 1377-1400.
17. Happe, F., Briskman, J., Frith, U. (2001). Exploring the cognitive phenotype of autism: weak "central coherence" in parents and siblings of children with autism: I Experimental tests. Journal of Child Psychology & Psychiatry, 42(3): 299-307.
18. Lamb, J.A., Parr, J.R., Bailey, A.J., Monaco, A.P. (2002). Autism: in search of susceptibility genes. Neuromolecular Medicine, 2(1): 11-28.
19. Cook, E.H., Jr. (2001). Genetics of autism. Child and Adolescent Psychiatric Clinics of North America, 10(2): 333-350.
20. Neul, J.L., Zoghbi, H.Y. (2004). Rett syndrome: a prototypical neurodevelopmental disorder. Neuroscientist, 10(2): 118-128.
21. Buitelaar, J.K., Willemsen-Swinkels, S.H. (2000). Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy. Paediatric Drugs, 2(1): 67-81.
22. Cook, E.H., Jr. (1998). Genetics of autism. Mental Retardation and Developmental Disabilities Research Reviews, 4(2): 113-120.
23. Gillberg, C., De Souza, L. (2002). Head circumference in autism, Asperger syndrome, and ADHD:
a comparative study. Developmental Medicine & Child Neurology, 44(5): 296-300.
24. Palmen, S.J., Van Engeland, H. (2004). Review on structural neuroimaging findings in autism. Journal of Neural Transmission, 111(7): 903-929.
25. Courchesne, E., Karns, C.M., Davis, H.R., Ziccardi, R., Carper, R.A., Tigue, Z.D., Chisum, H.J., Moses, P., Pierce, K., Lord, C., Lincoln, A.J., Pizzo, S., Schreibman, L., Haas, R.H., Akshoomoff, N.A., Courchesne, R.Y. (2001). Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology, 57(2): 245-254.
26. Courchesne, E., Carper, R., Akshoomoff, N. (2003). Evidence of brain overgrowth in the first year of life in autism. JAMA, 290(3): 337-344.
27. Cody, H., Pelphrey, K., Piven, J. (2002). Structural and functional magnetic resonance imaging of autism. International Journal of Developmental Neuroscience, 20(3-5): 421-438.
28. Glasson, E.J., Bower, C., Petterson, B., De Klerk, N., Chaney, G., Hallmayer, J.F. (2004). Perinatal factors and the development of autism: a population study. Archives of General Psychiatry, 61(6): 618-627.
29. Tidmarsh, L., Volkmar, F.R. (2003). Diagnosis and epidemiology of autism spectrum disorders. Canadian Journal of Psychiatry, 48(8): 517-525.
30. Madsen, K.M., Hviid, A., Vestergaard, M., Schendel, D., Wohlfahrt, J., Thorsen, P., Olsen, J., Melbye, M. (2002). A population-based study of measles, mumps, and rubella vaccination and autism. New England Journal of Medicine, 347(19): 1477-1482.
31. Howlin, P. (1997). Prognosis in autism: do specialist treatments affect long-term outcome? European Child & Adolescent Psychiatry, 6(2): 55-72.
32. Howlin, P., Goode, S., Hutton, J., Rutter, M. (2004). Adult outcome for children with autism. Journal of Child Psychology & Psychiatry, 45(2): 212-229.
33. Tsatsanis, K.D. (2003). Outcome research in Asperger syndrome and autism. Child and Adolescent Psychiatric Clinics of North America, 12(1): 47-63, vi.
34. Volkmar, F.R., Lord, C., Bailey, A., Schultz, R.T., Klin, A. (2004). Autism and pervasive developmental disorders. Journal of Child Psychology & Psychiatry, 45(1): 135-170.
35. Volkmar, F., Cook, E.H., Jr., Pomeroy, J., Realmuto, G., Tanguay, P. (1999). Practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. American Academy of Child and Adolescent Psychiatry Working Group on Quality Issues. Journal of the American Academy of Child and Adolescent Psychiatry, 38(12 Suppl): 32S-54S.
36. Goldstein, S., Schwebach, A.J. (2004). The comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: results of a retrospective chart review. Journal of Autism and Developmental Disorders, 34(3): 329-339.
37. Ghaziuddin, M., Ghaziuddin, N., Greden, J. (2002). Depression in persons with autism: implications for research and clinical care. Journal of Autism and Developmental Disorders, 32(4): 299-306.
38. Stock, M. (2004). Autism spectrum disorders (pervasive developmental disorders). Bethesda: National Institute of Mental Health.
39. Bastiaansen, D., Koot, H.M., Ferdinand, R.F., Verhulst, F.C. (2004). Quality of life in children with psychiatric disorders: self-, parent, and clinician report. Journal of the American Academy of Child & Adolescent Psychiatry, 43(2): 221-230.
40. Jarbrink, K., Knapp, M. (2001). The economic impact of autism in Britain. Autism, 5(1): 7-22.
41. Nicolson, R., Szatmari, P. (2003). Genetic and neurodevelopmental influences in autistic disorder. Canadian Journal of Psychiatry, 48(8): 526-537.
42. Van Berckelaer-Onnes, I.A. (2004). Zestig jaar autisme. Nederlands Tijdschrift voor Geneeskunde, 148(21): 1024-1030.
43. Baron-Cohen, S. (1991). The development of a theory of mind in autism: deviance and delay? Psychiatric Clinics of North America, 14(1): 33-51.
44. Begeer, S., Rieffe, C., Meerum Terwogt, M. (2004). Sociaal-emotionele competentie van normaal intelligente kinderen met autisme. In: A. Vyt, M.A.G. van Aken, J.D. Bosch, M.A.G. van der Gaag, A.J.J.M. Ruijssenaars (red.). Jaarboek ontwikkelingspsychologie, orthopedagogiek en kinderpsychiatrie 6 (2004-2005), p. 252-275. Houten: Bohn Stafleu Van Loghum.
45. Happé, F.G. (1995). The role of age and verbal ability in the theory of mind task performance of subjects with autism. Child Development, 66(3): 843-855.
46. Silliman, E.R., Diehl, S.F., Huntley Bahr, R., Hnath-Chisolm, T., Bouchard Zenko, C., Friedman, S.A. (2003). A new look at performance on theory-of-mind tasks by adolescents with autism spectrum disorder. Language, Speech, and Hearing Services in Schools, 34(July): 236-252.
47. Yirmiya, N., Erel, O., Shaked, M., Solomonica-Levi, D. (1998). Meta-analyses comparing theory of mind abilities of individuals with autism, individuals with mental retardation, and normally developing individuals. Psychological Bulletin, 124(3): 283-307.
48. Liss, M., Fein, D., Allen, D., Dunn, M., Feinstein, C., Morris, R., Waterhouse, L., Rapin, I. (2001). Executive functioning in high-functioning children with autism. Journal of Child Psychology & Psychiatry, 42(2): 261-270.
49. Geurts, H.M., Verté, S., Oosterlaan, J., Roeyers, H., Sergeant, J.A. (2004). How specific are executive functioning deficits in attention deficit hyperactivity disorder and autism? Journal of Child Psychology & Psychiatry, 45(4): 836-854.
50. Berger, H.J., Aerts, F.H., Van der Sijde, A., Bogart-Bex, P.A., Teunisse, J.P. (2002). Cognitieve stijlkenmerken bij jongeren met een autisme-spectrum-stoornis. Tijdschrift voor Psychiatrie, 44; 83-94.
51. Jolliffe, T., Baron-Cohen, S. (2000). Linguistic processing in high-functioning adults with autism or Asperger's syndrome. Is global coherence impaired? Psychological Medicine, 30(1169-1187.
52. Filipek, P.A., Accardo, P.J., Ashwal, S., Baranek, G.T., Cook, E.H., Jr., Dawson, G., Gordon, B., Gravel, J.S., Johnson, C.P., Kallen, R.J., Levy, S.E., Minshew, N.J., Ozonoff, S., Prizant, B.M., Rapin, I., Rogers, S.J., Stone, W.L., Teplin, S.W., Tuchman, R.F., Volkmar, F.R. (2000). Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology, 55(4): 468-479.
53. Smith, T. (1999). Outcome of early intervention for children with autism. Clinical Psychology: Science & Practice, 6(1): 33-49.
54. Bryson, S.E., Rogers, S.J., Fombonne, E. (2003). Autism spectrum disorders: early detection, intervention, education, and psychopharmacological management. Canadian Journal of Psychiatry, 48(8): 506-516.
55. Siegel, B., Pliner, C., Eschler, J., Elliott, G.R. (1988). How children with autism are diagnosed: difficulties in identification of children with multiple developmental delays. Journal of Developmental and Behavioral Pediatrics, 9(4): 199-204.
56. Howlin, P., Moore, A. (1997). Diagnosis in autism: a survey of over 1200 patients in the UK. Autism, 1(2): 135-162.
57. Bristol-Power, M.M., Spinella, G. (1999). Research on screening and diagnosis in autism: a work in progress. Journal of Autism and Developmental Disorders, 29(6): 435-438.
58. De Bildt, A.A. (2003). The Friesland study: pervasive developmental disorders in mental retardation. Enschede: PPI.
59. Ferdinand, R.F., Van Lier, M.H.M., Van der Most, G.H.F., De Nijs, P.F.A., Reichart, C.G., Dekkers, F.H.W. (2004). Meetinstrumenten bij psychiatrische stoornissen bij kinderen en jeugdigen. Tijdschrift voor Psychiatrie, 46(10): 659-664.
60. Baron-Cohen, S., Allen, J., Gillberg, C. (1992). Can autism be detected at 18 months? The needle, the haystack, and the CHAT. British Journal of Psychiatry, 161(839-843.
61. Baird, G., Charman, T., Cox, A., Baron-Cohen, S., Swettenham, J., Wheelwright, S., Drew, A. (2001). Current topic: Screening and surveillance for autism and pervasive developmental disorders. Archives of Disease in Childhood, 84(6): 468-475.
62. Kraijer, D.W. (2004). Handboek autismespectrumstoornissen en verstandelijke beperking. Lisse: Harcourt.
63. Tanguay, P.E. (2000). Pervasive developmental disorders: a 10-year review. Journal of the American Academy of Child and Adolescent Psychiatry, 39(9): 1079-1095.
64. Howlin, P. (1998). Practitioner review: psychological and educational treatments for autism. Journal of Child Psychology & Psychiatry, 39(3): 307-322.
65. Novotny, S. (2003). Pharmacological treatment of autism: a review. TEN: Trends in Evidence-Based Neuropsychiatry, 5(1): 43-60.
66. Broadstock, M., Doughty, C. (2003). The effectiveness of pharmacological therapies for young people and adults with Autism Spectrum Disorder (ASD): a critical appraisal of the literature. Christchurch: New Zealand Health Technology Assessment (NZHTA).
67. Bölte, S., Poustka, F. (2002). Intervention bei autistischen Störungen: Status quo, evidenzbasierte, fragliche und fragwürdige Techniken. Zeitschrift Kinder- und Jugendpsychiatrie und Psycho-therapie, 30(4): 271-280.
68. Buitelaar, J.K., Willemsen-Swinkels, S.H.N. (2000). Medication treatment in subjects with autistic spectrum disorders. European Child & Adolescent Psychiatry, 9(Suppl.1): I85-I97
69. Remington, G., Sloman, L., Konstantareas, M., Parker, K., Gow, R. (2001). Clomipramine versus haloperidol in the treatment of autistic disorder: a double-blind, placebo-controlled, crossover study. Journal of Clinical Psychopharmacology, 21(4): 440-444.
70. Findling, R.L., McNamara, N.K. (2004). Atypical antipsychotics in the treatment of children and adolescents: clinical applications. Journal of Clinical Psychiatry, 65 Suppl 6(30-44.
71. Barnard, L., Young, A.H., Pearson, J., Geddes, J., O'Brien, G. (2002). A systematic review of the use of atypical antipsychotics in autism. Journal of Psychopharmacology, 16(1): 93-101.
72. McCracken, J.T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M.G., Arnold, L.E., Lindsay, R., Nash, P., Hollway, J., McDougle, C.J., Posey, D., Swiezy, N., Kohn, A., Scahill, L., Martin, A., Koenig, K., Volkmar, F., Carroll, D., Lancor, A., Tierney, E., Ghuman, J., Gonzalez, N.M., Grados, M., Vitiello, B., Ritz, L., Davies, M., Robinson, J., McMahon, D. (2002). Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine, 347(5): 314-321.
73. McDougle, C.J., Naylor, S.T., Cohen, D.J., Volkmar, F.R., Heninger, G.R., Price, L.H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53(11): 1001-1008.
74. Di Martino, A., Tuchman, R.F. (2001). Antiepileptic drugs: affective use in autism spectrum disorders. Pediatric Neurology, 25(3): 199-207.
75. Willemsen-Swinkels, S.H., Buitelaar, J.K., Nijhof, G.J., Van Engeland, H. (1995). Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. Archives of General Psychiatry, 52(9): 766-773.
76. Sandler, A.D., Sutton, K.A., DeWeese, J., Girardi, M.A., Sheppard, V., Bodfish, J.W. (1999). Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. New England Journal of Medicine, 341(24): 1801-1806.
77. Patel, N.C., Yeh, J.Y., Shepherd, M.D., Crismon, M.L. (2002). Secretin treatment for autistic disorder: a critical analysis. Pharmacotherapy, 22(7): 905-914.
78. Nye, C., Brice, A. (2002). Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Systematic Reviews, CD003497.
79. Kleijnen, J., Knipschild, P. (1991). Niacin and vitamin B6 in mental functioning: a review of controlled trials in humans. Biological Psychiatry, 29(9): 931-941.
80. Zarcone, J.R., Hellings, J.A., Crandall, K., Reese, R.M., Marquis, J., Fleming, K., Shores, R., Williams, D., Schroeder, S.R. (2001). Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. American Journal on Mental Retardation, 106(6): 525-538.
81. McDougle, C.J., Holmes, J.P., Carlson, D.C., Pelton, G.H., Cohen, D.J., Price, L.H. (1998). A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders. Archives of General Psychiatry, 55(7): 633-641.
82. Millward, C., Ferriter, M., Calver, S., Connell-Jones, G. (2004). Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Systematic Reviews, CD003498.
83. Lord, C., McGee, J.P., Committee on Educational Interventions for Children with Autism, Division of Behavioral and Social Sciences and Education, N.R.C. (2001). Educating children with autism. Washington DC: National Academy Press.
84. Horner, R.H., Carr, E.G., Strain, P.S., Todd, A.W., Reed, H.K. (2002). Problem behavior interventions for young children with autism: a research synthesis. Journal of Autism and Developmental Disorders, 32(5): 423-446.
85. McConnell, S.R. (2002). Interventions to facilitate social interaction for young children with autism: Review of available research and recommendations for educational intervention and future research. Journal of Autism and Developmental Disorders, 32(351-372.
86. Diggle, T., McConachie, H.R., Randle, V.R. (2003). Parent-mediated early intervention for young children with autism spectrum disorder. Cochrane Database Systematic Reviews, CD003496.
87. Smith, T., Groen, A.D., Wynn, J.W. (2000). Randomized trial of intensive early intervention for children with pervasive developmental disorder. American Journal on Mental Retardation, 105(4): 269-285.
88. Marquis, J.G., Horner, R.H., Carr, E.G., Turnbull, A.P., Thompson, M., Behrens, G.A., Magito-McLaughlin, D., McAtee, M.L., Smith, C.E., Ryan, K.A., Doolabh, A. (2000). A meta-analysis of positive behavior support. In: R. Gersten, E.P. Schiller, S. Vaughn (red.). Contemporary special education research: Syntheses of the knowledge base on critical instructional issues, p. 137-178. Mahwah: Lawrence Erlbaum Associates.
89. Matson, J.L., Benavidez, D.A., Compton, L.S., Paclawskyj, T., Baglio, C. (1996). Behavioral treatment of autistic persons: a review of research from 1980 to the present. Research in Developmental Disabilities, 17(6): 433-465.
90. Finch, L., Raffaele, C. (2003). Intensive behavioural intervention for children with autism: a review of the evidence. Occupational Therapy Now, 5(4): 20-23.
91. McEachin, J.J., Smith, T., Lovaas, O.I. (1993). Long-term outcome for children with autism who received early intensive behavioral treatment. American Journal on Mental Retardation, 97(4): 359-372.
92. Delprato, D.J. (2001). Comparisons of discrete-trial and normalized behavioral language intervention for young children with autism. Journal of Autism and Developmental Disorders, 31(3): 315-325.
93. Sinha, Y., Silove, N., Wheeler, D., Williams, K. (2004). Auditory integration training and other sound therapies for autism spectrum disorders. Cochrane Database Systematic Reviews, CD003681.
94. Werkgroep Sociale Kaart Autisme Nederland, Voortman, A., Heijmen, A., Borgmeijer, E.-J., Poort, I., Vonk, I., Feenstra, T. (2003). Sociale kaart autisme Nederland. Doorwerth: Kenniscentrum Autisme Nederland (KAN).
95. Kok, I., De Lege, W., Koedoot, P., Swets-Gronert, F. (1991). Hulpverlening aan autisten: onderzoek naar de RIAGG-autismeteams. Utrecht: Nederlands centrum Geestelijke volksgezondheid.
96. Van den Ende, A.W. (2004). Ontwikkeling wachtlijsten en zorgvraag in de verstandelijk gehandicaptenzorg. Diemen: College voor Zorgverzekeringen.